Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07321522 · ClinicalTrials.gov registry record · NA

Early Introduction and Sustained Ingestion (EISI) Using Two Educational Opportunities in Infants

A NA study, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
92
Enrollment target

NCT07321522: Recruiting NA study, sponsored by Stanford University.

NCT07321522 is a NA study that is actively recruiting participants, run by Stanford University. The registered enrollment target is 92 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07321522, a NA study, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
92 participants
Enrollment target

Study Summary

The objective of the study is to see whether early feeding of potentially allergic foods can be increased with educational materials alone or with educational materials and additional in-person support opportunities. This study will help guide what types of support pediatricians and allergists give to new parents.

Interventions

  • BEHAVIORAL Education and Opportunities on Early Introduction
  • BEHAVIORAL Clinician Supervised Feeding of Known Allergenic Food

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2026-06-30
Est. Completion 2028-02
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT07321522

The ClinicalTrials.gov registry entry for NCT07321522 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Education and Opportunities on Early Introduction is the first listed.

NCT07321522 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07321522 about?

NCT07321522 is a clinical study titled "Early Introduction and Sustained Ingestion (EISI) Using Two Educational Opportunities in Infants". The objective of the study is to see whether early feeding of potentially allergic foods can be increased with educational materials alone or with educational materials and additional in-person support opportunities. This study will help guide what types of support pediatricians and allergists give ...

What is the current status of trial NCT07321522?

This trial is currently recruiting. It is a NA study. The enrollment target is 92 participants. The study started on 2026-06-30. Estimated completion is 2028-02.

What interventions are being tested in trial NCT07321522?

The interventions under investigation include: Education and Opportunities on Early Introduction (BEHAVIORAL), Clinician Supervised Feeding of Known Allergenic Food (BEHAVIORAL).

Who is sponsoring clinical trial NCT07321522?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.